Lipid vesicles for skin delivery of drugs: reviewing three decades of research
- PMID: 17222523
- DOI: 10.1016/j.ijpharm.2006.12.005
Lipid vesicles for skin delivery of drugs: reviewing three decades of research
Abstract
Since liposomes were first shown to be of potential value for topical therapy by Mezei and Gulasekharam in 1980, studies continued towards further investigation and development of lipid vesicles as carriers for skin delivery of drugs. Despite this long history of intensive research, lipid vesicles are still considered as a controversial class of dermal and transdermal carriers. Accordingly, this article provides an overview of the development of lipid vesicles for skin delivery of drugs, with special emphasis on recent advances in this field, including the development of deformable liposomes and ethosomes.
Similar articles
-
Vesicular carriers for dermal drug delivery.Expert Opin Drug Deliv. 2009 Aug;6(8):813-25. doi: 10.1517/17425240903071029. Expert Opin Drug Deliv. 2009. PMID: 19569979 Review.
-
Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.J Control Release. 2007 Nov 6;123(2):148-54. doi: 10.1016/j.jconrel.2007.08.005. Epub 2007 Aug 16. J Control Release. 2007. PMID: 17884226
-
Deformable liposomes and ethosomes: mechanism of enhanced skin delivery.Int J Pharm. 2006 Sep 28;322(1-2):60-6. doi: 10.1016/j.ijpharm.2006.05.027. Epub 2006 May 19. Int J Pharm. 2006. PMID: 16806755
-
Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil.Int J Pharm. 2009 Oct 1;380(1-2):72-9. doi: 10.1016/j.ijpharm.2009.06.040. Epub 2009 Jul 7. Int J Pharm. 2009. PMID: 19589377
-
Liposomes and skin: from drug delivery to model membranes.Eur J Pharm Sci. 2008 Aug 7;34(4-5):203-22. doi: 10.1016/j.ejps.2008.05.002. Epub 2008 May 8. Eur J Pharm Sci. 2008. PMID: 18572392 Review.
Cited by
-
Improved skin permeation of methotrexate via nanosized ultradeformable liposomes.Int J Nanomedicine. 2016 Aug 8;11:3813-24. doi: 10.2147/IJN.S109565. eCollection 2016. Int J Nanomedicine. 2016. PMID: 27540293 Free PMC article.
-
Therapeutic and cosmeceutical potential of ethosomes: An overview.J Adv Pharm Technol Res. 2010 Jul;1(3):274-82. doi: 10.4103/0110-5558.72415. J Adv Pharm Technol Res. 2010. PMID: 22247858 Free PMC article.
-
Design and Optimization of Orally Administered Luteolin Nanoethosomes to Enhance Its Anti-Tumor Activity against Hepatocellular Carcinoma.Pharmaceutics. 2021 May 2;13(5):648. doi: 10.3390/pharmaceutics13050648. Pharmaceutics. 2021. PMID: 34063274 Free PMC article.
-
Evaluation of octyl p-methoxycinnamate included in liposomes and cyclodextrins in anti-solar preparations: preparations, characterizations and in vitro penetration studies.Int J Nanomedicine. 2012;7:3045-58. doi: 10.2147/IJN.S28550. Epub 2012 Jun 20. Int J Nanomedicine. 2012. PMID: 22787399 Free PMC article.
-
Thymoquinone-loaded lipid vesicles: a promising nanomedicine for psoriasis.BMC Complement Altern Med. 2019 Nov 27;19(1):334. doi: 10.1186/s12906-019-2675-5. BMC Complement Altern Med. 2019. PMID: 31771651 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources